ASBP — Aspire Biopharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $5.33m
- $9.50m
- $0.01m
Annual cashflow statement for Aspire Biopharma Holdings, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | — | USG | USG | USG | USG |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | 3.34 | 4.46 | -12.5 | -24.5 |
| Non-Cash Items | — | -4.32 | -5.8 | 9.45 | 19 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | -0.432 | 0.687 | 1.03 | 0.533 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | — | -1.41 | -0.653 | -2.05 | -4.92 |
| Other Investing Cash Flow Items | — | -295 | 285 | 13.8 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -295 | 285 | 13.8 | — |
| Financing Cash Flow Items | — | 297 | 0 | — | -0.907 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 297 | -285 | -11.7 | 5.92 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | 0.497 | -0.497 | 0 | 1 |